BCDA
No price yet
Announcements
Daily updates
FDA designations
Nothing here yet
News
- BioCardia completed the clinical consultation process with Japan’s PMDA for its CardiAMP Cell Therapy System, advancing toward submission of a marketing approval application.Nov 6, 2026
- BioCardia receives FDA acceptance of its De Novo pre-submission package for Helix catheter marketing clearance, with substantive review and a meeting expected this quarterOct 19, 2026
- BioCardia presents the CardiAMP HF II trial design at the Heart Failure Society of America Annual Scientific MeetingOct 7, 2026
- BioCardia files a revised FDA De Novo pre-submission for the Helix transendocardial delivery catheterOct 1, 2026
- BioCardia says Japan PMDA guidance supports regulatory filing for CardiAMP cell therapy in ischemic heart failureMay 28, 2026